Reporting owner · CIK 0001907056
Okupe Oluyemi
SEC Form 4 history across 1 companies, 18 transactions and 5 filings.
CFOChief Financial OfficerHims Hers Health, Inc.
Open-market transaction mix0% buys0 buys · 6 sales
Available history · Jun 18, 2026 – Oct 01, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | S · sale10b5-1 detectedSEC filing ↗ | -$59.4kView disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | S · sale10b5-1 detectedSEC filing ↗ | -$876kView disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | M · exercise10b5-1 detectedSEC filing ↗ | $70.1kView disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | S · sale10b5-1 detectedSEC filing ↗ | -$354kView disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | S · sale10b5-1 detectedSEC filing ↗ | -$148kView disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | M · exercise10b5-1 detectedSEC filing ↗ | $24.7kView disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | S · sale10b5-1 detectedSEC filing ↗ | -$261kView disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | M · exercise10b5-1 detectedSEC filing ↗ | $47.0kView disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | F · withholding10b5-1 detectedSEC filing ↗ | -$1.02MView disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | M · exercise10b5-1 detectedSEC filing ↗ | UnknownView disclosure → | |
HIMSHims Hers Health, Inc. | Okupe OluyemiCFO | S · sale10b5-1 detectedSEC filing ↗ | -$1.94MView disclosure → |
Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
sale at Hims Hers Health, Inc. on Oct 01, 2026 valued at $59,400.
Review SEC filingLatest buy
No open-market insider purchase is available.
Monthly open-market activity
Last 4 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| Jun 2026 | 0 | 1 | $0.00 | $1,943,389.47 | -$1,943,389.47 |
| Aug 2026 | 0 | 2 | $0.00 | $409,913.58 | -$409,913.58 |
| Sep 2026 | 0 | 2 | $0.00 | $1,231,706.81 | -$1,231,706.81 |
| Oct 2026 | 0 | 1 | $0.00 | $59,400.00 | -$59,400.00 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size$607.4K
Median P/S size$308.3K
Direct18
Indirect0
Oct 01, 2026sale
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
No open-market purchases in available history
A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
11 observations · Jun 18, 2026 – Oct 1, 2026. Window ends at the latest available report, not today.
Selected observation · Oct 1, 2026234,527 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Jun 18, 2026 | 228,938 | Aug 18, 2026 | View transaction |
| Aug 14, 2026 | 300,554 | Aug 18, 2026 | View transaction |
| Aug 14, 2026 | 264,117 | Aug 18, 2026 | View transaction |
| Aug 17, 2026 | 273,505 | Aug 18, 2026 | View transaction |
| Aug 17, 2026 | 264,117 | Aug 18, 2026 | View transaction |
| Aug 19, 2026 | 269,055 | Aug 20, 2026 | View transaction |
| Aug 19, 2026 | 264,117 | Aug 20, 2026 | View transaction |
| Sep 17, 2026 | 251,804 | Sep 18, 2026 | View transaction |
| Sep 22, 2026 | 265,804 | Sep 23, 2026 | View transaction |
| Sep 22, 2026 | 236,527 | Sep 23, 2026 | View transaction |
| Oct 1, 2026 | 234,527 | Oct 2, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Okupe Oluyemi Insider Activity FAQ
SEC Form 4 context
Who is Okupe Oluyemi?
Okupe Oluyemi is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001907056.
Which companies has Okupe Oluyemi reported transactions for?
Hims Hers Health, Inc.
When was Okupe Oluyemi's latest insider buy?
No open-market insider purchase is available for this period.
When was Okupe Oluyemi's latest insider sale?
sale at Hims Hers Health, Inc. on Oct 01, 2026 valued at $59,400.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.